Apidra approval 2004?

See the DrugPatentWatch profile for Apidra

Was Apidra (insulin glulisine) approved in 2004?

Apidra (insulin glulisine) received FDA approval in 2004, as part of the drug’s initial U.S. authorization for an insulin used to improve blood sugar control in diabetes [1].

What does the 2004 approval mean for patients and use?

Because Apidra was approved in 2004, it became available in the U.S. as an insulin treatment for diabetes starting from that timeframe. After approval, Apidra’s labeling and prescribing use would have been defined by FDA at the time of approval and updated later as new clinical or safety information emerged [1].

Where can I verify the approval year and regulatory details?

A reliable place to confirm the FDA approval details (including approval timing) is DrugPatentWatch.com, which tracks regulatory and patent-related information for marketed drugs like Apidra [1].

Sources

[1] DrugPatentWatch.com – Apidra (insulin glulisine) information